US 11185575
Subcutaneous administration of ADAMTS13
granted A61KA61K38/4886A61K9/0019
Quick answer
US patent 11185575 (Subcutaneous administration of ADAMTS13) held by Takeda Pharmaceutical Company Limited expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/4886, A61K9/0019, A61K9/19, A61P